학술논문

Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses
Document Type
Artikel
Source
The Journal of allergy and clinical immunology. 138(4):1051-1059
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1097-6825